Neela Paykel - Oct 31, 2022 Form 4 Insider Report for Hyperfine, Inc. (HYPR)

Role
Gen Counsel & Corp Secretary
Signature
/s/ Alok Gupta
Stock symbol
HYPR
Transactions as of
Oct 31, 2022
Transactions value $
$0
Form type
4
Date filed
11/1/2022, 05:55 PM
Previous filing
Aug 16, 2022
Next filing
Nov 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HYPR Stock Option (right to buy) Disposed to Issuer -71.8K -100% 0 Oct 31, 2022 Class A Common Stock 71.8K $3.90 Direct F1
transaction HYPR Stock Option (right to buy) Award +71.8K 71.8K Oct 31, 2022 Class A Common Stock 71.8K $0.91 Direct F1
transaction HYPR Stock Option (right to buy) Disposed to Issuer -85K -100% 0 Oct 31, 2022 Class A Common Stock 85K $3.90 Direct F2
transaction HYPR Stock Option (right to buy) Award +85K 85K Oct 31, 2022 Class A Common Stock 85K $0.91 Direct F2
transaction HYPR Stock Option (right to buy) Disposed to Issuer -98.3K -100% 0 Oct 31, 2022 Class A Common Stock 98.3K $3.27 Direct F3
transaction HYPR Stock Option (right to buy) Award +98.3K 98.3K Oct 31, 2022 Class A Common Stock 98.3K $0.91 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 25,411 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.
F2 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Ms. Paykel's continued service through the applicable vesting date.
F3 The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 30,702 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.